School of Pharmacy - Central Web Server 2 - University of Connecticut

School of PharmacyAnnual Report 2003 - 2004

Upcoming EventsJanuary 20051/18 White Coat CeremonyLewis B. Rome BallroomFebruary 20052/10 Job FairLewis B. Rome BallroomMarch 20053/3 Scholarship ReceptionLewis B. Rome BallroomApril 20054/12 Career NightLewis B. Rome BallroomContentsFaculty & Staff 1Dean’s Message 2Alumni News 4Alumni Update 5Alumni Awardees 6Rosenberg-CohenSymposium 8Connecticut PharmacyLeadership Group 9Alumni AssociationLife Members 9In Memoriam 9New Scholarships 10Campaign UConn 10Beach Society 11Harry & Selma Swatsburg 11Pfizer Endowed Chair 12Graduates 14Student News 16New Haven Initiative 17Curriculum Update 18Pharmacy EducationManagement System 18Advisory Board 19New Faculty 19Faculty PublicationsPharmaceutical Sciences 20ASCP Training Program 20Antimicrobial Resistance 21Faculty PublicationsPharmacy Practice 22Patient Counseling Lab 23Neurotoxicology Center 23Residents & Fellows 23Boehringer Ingelheim 24Building Update 24May 20055/7 Commencement DayHooding Ceremony andAwards Brunch5/8 Undergraduate Reception5/18 Arthur E. SchwartingPharmacy PracticeSymposiumLewis B. Rome BallroomOctober 200510/21-22 Building DedicationCeremony and EventsOn the Cover:Pfizer representatives, School of Pharmacy graduate students, andProfessor Michael Pikal at the June 23, 2004 announcement of thePfizer Distinguished Endowed Chair in Pharmaceutical Technology.On the Back Cover:Work continues on the new Pharmacy/Biology Building. Interiorspaces, such as laboratories and the library, are well on the way tocompletion.Special Thanks to all of those who contributed their time and talents to the publication of this Annual Report:Jeffrey Aeschlimann, Elizabeth Anderson, Ben Bahr, Alex Bothell, Dennis Chapron, Tina Covensky, Davis Brody Bond, LLP Architects,Jennifer Doak, Kim Deely Emery, Neil Facchinetti, Gerald Gianutsos, Sandra Goss, Philip Hritcko, Andrea Hubbard, Thomas Hurlbut, BrianLachapelle, Ronald Langner, Leslie LeBel, Daniel Leone, Karen Logan, Paula Mattsson, Peter McAvoy, Sarah McCabe, Robert McCarthy, LizPallilo, Josie Pittman, Arthur Sorrentino, Kenneth Speranza, Sr.University of ConnecticutSchool of Pharmacy372 Fairfield Road ~ Unit 2092Storrs, Connecticut 06269-2092Telephone: (860) 486-2129 Facsimile: (860) 486-1553UConn’s School of Pharmacy is accredited by theAmerican Council on Pharmaceutical Education.The University of Connecticut is accredited by theNew England Association of Schools and Colleges.

Faculty & StaffAdministrative StaffExternal RelationsSupport StaffRobert L. McCarthy, Ph.D.Dean, Interim Department Head, andProfessorKenneth A. Speranza, Sr., Ph.D.Associate Dean and Associate ProfessorJohn B. Morris, Ph.D.Department Head and ProfessorElizabeth AndersonKim Deely EmeryBarbara MurawskiPharmacy LibrarySharon GiovenaleLibrarianSue DonnellyJenna HendersonWanda JoyLeslie LeBelKaren S. LoganPaula MattssonPaul SheaMargaret TartsinisAlumni RelationsPharmacy PracticePharmaceutical SciencesDaniel C. Leone, Executive SecretarySchool of Pharmacy AlumniAssociationContinuing EducationJeffrey R. Aeschlimann, Pharm.D.Assistant ProfessorCharles F. Caley, Pharm.D.Associate Clinical ProfessorJennifer James, Pharm.D.Assistant Clinical ProfessorSean M. Jeffery, Pharm.D.Assistant Clinical ProfessorBrian J. Aneskievich, Ph.D.Assistant ProfessorBen A. Bahr, Ph.D.Associate ProfessorDevendra S. Kalonia, Ph.D.Associate ProfessorRonald O. Langner, Ph.D.ProfessorHenry A. PalmerDirector of Continuing EducationMarla J. Campbell, Pharm.D.Assistant Clinical ProfessorLisa Larive, Pharm.D.Assistant Clinical ProfessorDiane Biegel, Ph.D.Assistant Research ProfessorAlexandros Makriyannis, Ph.D.ProfessorMary Ann PhaneufAssistant DirectorDevelopmentBrian J. Lachapelle, MBADirector of DevelopmentExperiential EducationPhilip Hritcko, Pharm.D.Director of Experiential EducationMary Ann PhaneufAssistant DirectorAndre LacombeField CoordinatorMary PetruzziField CoordinatorDennis J. Chapron, M.S.Associate ProfessorCraig Coleman, Pharm.D.Assistant ProfessorKhanh (Devra) Dang, Pharm.D.Assistant Clinical ProfessorJennifer Ellis, Pharm.D.Assistant Clinical ProfessorNeil J. Facchinetti, Ph.D.Associate ProfessorMichael C. Gerald, Ph.D.ProfessorPhilip Hritcko, Pharm.D.Assistant Clinical ProfessorRobert L. McCarthy, Ph.D.Dean, Interim Department Head, andProfessorTrinh Pham, Pharm.D.Assistant Clinical ProfessorKenneth A. Speranza, Sr., Ph.D.Associate Dean and AssociateProfessorFei Wang, Pharm.D.Assistant Clinical ProfessorC. Michael White, Pharm.D.Associate ProfessorRobin H. Bogner, Ph.D.Associate ProfessorMarlene Bouvier, Ph.D.Associate ProfessorDiane J. Burgess, Ph.D.ProfessorGerald Gianutsos, Ph.D.Associate ProfessorDavid F. Grant, Ph.D.Associate ProfessorJames G. Henkel, Ph.D.Associate ProfessorAndrea K. Hubbard, Ph.D.Associate ProfessorJosé Manautou, Ph.D.Associate ProfessorJohn B. Morris, Ph.D.Department Head and ProfessorCharles Nightingale, Ph.D.Research ProfessorSpyros Nikas, Ph.D.Assistant Research ProfessorSpiro Pavlopoulous, Ph.D.Assistant ProfessorMichael Pikal, Ph.D.ProfessorGanesh Thakur, Ph.D.Assistant Research ProfessorFor more information about the School of Pharmacy, visit our website at: www.pharmacy.uconn.eduPictured Above: Department of Pharmacy Practice faculty membersCraig Coleman, Philip Hritcko and Michael Gerald at the May2004 Commencement ceremony.

Dr. Robert L. McCarthy, DeanDear Friends:I am pleased to submit my third annual report as Dean of theSchool of Pharmacy. The 2003-2004 academic year was one to“celebrate.” Let me share with you some of the year’s highlights:In June, during a joint newsconference on the Storrscampus, Pfizer and the Schoolof Pharmacy celebrated theestablishment of the PfizerDistinguished Chair inPharmaceutical Technology.This $2 million gift, which ismatch-eligible from the State($1 million), represents thelargest gift ever given to theSchool and only the fourthDistinguished Chair at theUniversity of Connecticut. Itis also only the third Chairever given by Pfizer in theUnited States (the others are atDuke and Stanford).We celebrated the half-waypoint in the construction ofthe new Pharmacy/BiologyBuilding, which is slightly aheadof schedule for a spring 2005completion. We plan tocombine the buildingdedication, annual pharmacyalumni banquet, and 80 thanniversary celebration of theSchool into a festive weekendtentatively scheduled forFriday-Saturday, October 21-22,2005.The Office of ExperientialEducation welcomed a newleader, Dr. Philip Hritcko, asDirector and celebrated thepromotion of long-time staffmember Mary Ann Phaneuf tothe position of AssistantDirector of ContinuingEducation and ExperientialEducation. The staff of theOffice of ExperientialEducation completed work onimplementation of thePharmacy EducationManagement System (PEMS).PEMS not only assigns studentsto sites electronically, but alsoallows student, preceptor, andsite evaluations to becompleted on-line. The staffalso began work on an e-portfolio pilot project, whichwill allow for the developmentof a student portfolio of workthat can move with the studentfrom rotation to rotation asthey complete their advancedpractice experiences.The School celebrated thecareers of two belovedemeritus faculty, Drs. PhilipRosenberg and Steven Cohen,

y establishing the Rosenberg/Cohen Fellowships inPharmacology/Toxicology.We celebrated the formation ofthe Connecticut PharmacyLeadership Group. This group,representing the variouspharmacy organizations in thestate, will attempt to fostercommunication andcooperation on the manypublic policy issues facing theprofession.CelebrateDrs. Neil Facchinetti andJennifer James celebrated theavailability of new, state-of-artrecording equipment to assessand provide feedback tostudents engaged in patientcounseling activities. The newsystem allows adjunct faculty toview and evaluate students onlinefrom remote locations.We celebrated MayCommencement with ourAnnual Hooding Ceremonyand Brunch. School ofPharmacy Teacher of the Year,Dr. C. Michael White, delivereda lighthearted address as thekeynote speaker, and Dr.Ronald Langner was selected asthe first recipient of theFaculty Service Award for hiswork as Chair of the SchoolBuilding Committee.The Professionalism Task Force,under the leadership of Dr.Gerry Gianutsos, made a seriesof preliminaryrecommendations, which willallow us to nurture andcelebrate professional attitudesand behaviors by our students.We celebrated the work of theSchool of Pharmacy AdvisoryBoard, which continues to beactive in all aspects of Schoollife. During both its Octoberand April meetings, it brokeinto working groups to exploreseveral important issues facingthe School includingentrepreneurship, experientialeducation, curricular reform,and technology needs.We celebrated the establishmentof a partnership between theSchool of Pharmacy and theNew Haven Public Schools toincrease the number of underrepresentedminorities inpharmacy. We hope to receiveboth chain pharmacy andpharmaceutical industry supportfor this initiative.We celebrated theaccomplishments of BanuZolnik, a graduate studentworking with Dr. Diane Burgess,one of only four students fromschools of pharmacy nationwideselected as a 2004-2005 USPFellow.We celebrated the establishmentof the Hewitt Scholar inResidence Program. Thisprogram, funded from anendowment established by the3rd Dean of the School ofPharmacy, Harold Hewitt, willbring one to two nationallyrecognizedscholars to campuseach year for an intensive periodof scholarly exchange withfaculty members, post-docs,graduate students, residents, andfellows.Fund-raising for the School ofPharmacy Endowment for the21 st Century continues to goexceptionally well. Wecelebrated a year in which over$3.2 million was raised,highlighted by the Pfizer chairand gifts from Advisory BoardChair Joe Papa and a pledgefrom Boehringer Ingelheim of$250,000, at the time thelargest gift in the School’shistory, to name the DosageForms Teaching Laboratory.We also celebrated our first“snow bird” reception this pastFebruary in Florida hosted byBud and Brenda Roth.We bid a fond farewell to andcelebrated the accomplishmentsof Dr. Alex Makriyannis, aftermore than thirty years as oneof the University’s and world’spre-eminent medicinalchemistry researchers.Quite a year! On behalf of allof us in the School ofPharmacy, I extend myheartfelt appreciation for yourunwavering support. The newyear is certain to provide uswith many more reasons tocelebrate!With warm regards,Robert L. McCarthy, Ph.D.Dean and Professor3

Alumni UpdateOFFICERS 2003-2005Richard S. Bromberg ‘60announces that PiercePharmacy, Hartford, CT,established in 1886, has closedafter 40 years under hisownership. He is currentlyemployed by its purchaser,CVS Pharmacy.Laurence D. Runsdorf ‘61 hasjoined his classmates, BuddyRoth and Sam Kalmanowitz, bymaking a $100,000 gift to theSchool. His gift will name theDean’s Conference Room.AlumniDiana F. Thompson ‘66 isdisabled, but now workingactively on drug patent/license.Jeffrey D. Urman ‘67 isPhysician-in-Charge at KaiserPermanente, Mountain View,CA and is Professor ofMedicine at StanfordUniversity. He and his wife of34 years have two sons andlive in Palo Alto, CA.Ralph M. Stanzione ‘72 sold hispharmacy in October 2002 toan independent owner and isan Associate at Sterling CapitalPartners. His wife, Diana, hastaken a leadership role insaving the pharmacy medicinaldrug garden, which will bemoved to the new schoollocation. She is seekingvolunteers to help with thiseffort.Peter Tyczkowski ‘78 receivedthe 2004 ProfessionalPharmacy PersonnelProfessional PharmacyPerformance Award at theannual Connecticut PharmacistsAssociation meeting. He wasalso installed as 1 st Vice-President of the association.Joyce Kamanitz ‘83 has been inthe private practice ofPsychiatry in Hartford, CTsince 1992, specializing inpsychopharmacology andgender issues in psychiatry.She reports that her pharmacyeducation has been a great helpin her daily practice. She notesthat her father owned apharmacy in Maryland for over50 years and that her sister is apracticing pharmacist in NewJersey. She send regards to allher classmates and a specialhello to Ed Martucci who washer externship preceptor atKazarian’s Pharmacy inHartford, CT.Stephen J. Sand ‘85 is SeniorCounsel, Office of the GeneralCounsel at PurduePharmaceuticals in Stamford,CT.Charles A. Ritrovato ‘85 hasbeen promoted to Senior VicePresident, Drug Developmentand Regulatory Affairs atNeurogen Corporation inBranford, CT.Leslie (Aroh) Raycraft ‘88 andher husband, Joseph, announcethe birth of twin boys, HaydenJames and Cole Grant.Wendy (McKaige) Brackett ‘91is a Senior Scientist at Procterand Gamble in Cincinnati, OH.Tracy (Spruill) Bourbeau ‘93was married to Mark Bourbeauon December 13, 2003. She isemployed at HannafordPharmacy in Concord, NH.Michelle (Koe) Page ‘94 wasinstalled as President of theConnecticut PharmacistsAssociation at the annualmeeting in June 2004.Domenic Sammarco ‘97 (Hon.)has been awarded the 2004Wyeth Bowl of Hygeia by theConnecticut PharmacistsAssociation for his service tothe community.Lisa (Rosenberg) Banks ‘98 andher husband, Dave, also aUConn graduate, announce thebirth of their first son, HaydenMatthew, on January 6, 2004weighing 6 lbs. 15 oz.Valerie (Castellani) Sheehan ‘98was married to her husband,John, in October 2002. She isenjoying her job as ClinicalPharmacist, Drug Informationat the Baylor UniversityMedical Center in Dallas, TX.She appreciated receiving thenewsletter and can’t wait tovisit UConn and see the newSchool of Pharmacy building.Christopher Lopez ‘01 receivedthe 2004 Pharmacists MutualDistinguished YoungPharmacist Award at theConnecticut PharmacistsAssociation annual meeting.PresidentJennifer Osowiecki ‘85Vice-PresidentMichael Moore ’94SecretaryJacqueline Murphy ‘78TreasurerAustin Bebyn ‘86Executive SecretaryDaniel C. Leone ‘53BOARD OF DIRECTORSTERM EXPIRES MAY 2007Martha Asarisi ‘81Jennifer Clayman ‘04Joyce Comer ‘75Margherita Giuliano ‘75V. Michael Guertin ‘66Ellen Konspore ‘79Donald K. Zettervall ‘79TERM EXPIRES MAY 2006Robert Dana ‘63Sherman R. Gershman ‘51Keith Lyke ‘92Edward Sklanka ‘74Peter Tyczkowski ‘78Elliot Tertes ‘62Christopher Weimer ‘94TERM EXPIRES MAY 2005Edgar Albuja ‘93Richard Bromberg ‘60John Capuano ‘73Thomas M. Corazzo ‘72Mary Ryan Norbut ‘92William Ward ‘66Kathleen Wozniak ‘92STUDENT REPRESENTATIVESEllen Kozikowski ‘05Sarah McCabe ‘065

Alumni AwardeesFirst Row: Distinguished Alumnus Richard T. Carbray, Jr. ‘75 B.S., Owner, Apex Pharmacy, Hamden,CT; Pharmacy Alumni Association President Jennifer Osoweiecki ‘85; Distinguished Emeritus ProfessorHenry A. Palmer ‘60, ‘64; School of Pharmacy Dean Robert L. McCarthy.Second Row: Honorary Alumnus Peter R. Farina, Vice President Development, Boehringer IngelheimPharmaceutical, Inc.; Distinguished Alumnus Stanley L. Hem ‘65 Ph.D., Professor of Physical Pharmacy,Purdue University; Distinguished Alumnus Galen Radebaugh ‘78 Ph.D., Vice President AnalyticalDevelopment, Schering-Plough Research Institute; Honorary Alumnus Richard W. Foote, Owner, ABP/Pharmex Company.Honored as DistinguishedAlumni were Richard T.Carbray Jr., representingpharmacy practice, Dr. StanleyL. Hem, representing academiaand Dr. Galen W. Radebaugh,representing thepharmaceutical industry. Dr.Henry A. Palmer, EmeritusFaculty member of the School,was named as the first recipientof the Distinguished EmeritusFaculty Award presented bythe Pharmacy AlumniAssociation. Dr. Peter Farinaand Richard W. Foote werenamed as Honorary PharmacyAlumni Association members.These awards are given to non-UConn School of Pharmacygraduates who have made anoutstanding contribution tothe School or the profession.Richard T. Carbray Jr.Pharmacy PracticePharmacist Carbray is a 1975graduate of the School earninga B.S. Pharmacy degree. Hebegan his career in communitypharmacy working at McNeil’sPharmacy in Cromwell, CT and,then, Ferndale Drug inKensington, CT. From 1983-1985, he was a professional salesrepresentative for ScheringLaboratories. In 1985, hereturned to communitypharmacy as Vice-President ofPelton’s Pharmacy and HomeHealth Center in Middletown,CT. In 2003, he purchasedApex Pharmacy and HomeHealth Center in Hamden, CT.He has been active inprofessional and public affairs.He is a past President of theUConn Pharmacy AlumniAssociation and theConnecticut PharmacistsAssociation. He is presentlythe Vice-President of theUConn Alumni Association.His involvement in thecommunity is extensive,serving on the Newington, CTTown Council since 1997 andas its majority leader since2001. He is a past member ofthe Wethersfield Chamber ofCommerce Board of Directors,the Wethersfield VisitingNurses Association, theMiddletown Visiting NursesDUR Committee and severalother organizations. He is apast member of the NewingtonDemocratic Town Committee.Among the awards he hasreceived are Irish Person of theYear 2000, A. H. Robins Bowlof Hygeia for communityservice 1996 and ConnecticutPharmacist AssociationPharmacist of the Year in 1998.Con

Dr. Stanley L. HemAcademiaDr. Hem received his B.S. inPharmacy from RutgersUniversity in 1961 and his Ph.D.in Pharmaceutics from theUniversity of Connecticut in1965. After serving as a SeniorResearch Pharmacist inresearch and development atWyeth Laboratories, he took aposition as Assistant Professorof Physical Pharmacy at PurdueUniversity in 1969. In 1976, hebecame Professor of PhysicalPharmacy. He has served asAssistant Dean, GraduateSchool 1980-1983, andChairman of the UniversitySenate. He was a member ofthe USP Revisions Committeefrom 1995-2000. He holdsnumerous patents and serves asa consultant to severalpharmaceutical companies.Among the awards he hasreceived are the AmericanAssociation of PharmaceuticalSciences Research AchievementAward 1993, AACPOutstanding TeacherRecognition Award 2002,Henry Heine Award forExcellence in Teaching and theOutstanding ResearchPublication Award, from theJournal of PharmaceuticalSciences 1970. He has servedas a major advisor for dozensof pre- and post-doctoralstudents.Dr. Galen W. RadebaughPharmaceutical IndustryDr. Radebaugh received his B.S.in Pharmacy from theUniversity of Michigan Collegeof Pharmacy in 1972 and hisPh.D. in Pharmaceutics fromthe University of Connecticutin 1978. In 1981, he joinedSmith Kline BeckmanCorporation as AssociateSenior Investigator,Formulations and in 1982became Senior Investigator andSupervisor. In 1983, he joinedthe Johnson and JohnsonCorporation as Group Leader,Drug Delivery and ExploratoryResearch. From 1993 to 1999,he held various positions withthe Parke-Davis Company inpharmaceutical research. Since1999, he has been VicePresident, AnalyticalDevelopment at the Schering-Plough Research Institutewhere, among other duties, heis responsible for about 300professionals in the U.S. andSwitzerland, and leads theSpecifications DevelopmentCommittee for all products indevelopment worldwide. Hewas elected a Fellow of theAmerican Association ofPharmaceutical Scientists in1997, received the AAPS-BIOTEC award for best appliedR&D poster (co-awardee) 1993and the J&J Philip B. HoffmanResearch Scientist award 1987.He has held chairmanships andmemberships on manyprofessional committees. Heholds fourteen primary patents,has written several books andbook chapters, many journalarticles, and has made manypresentations to pharmaceuticsprofessionals.gratulationsDr. Henry A. PalmerDistinguished EmeritusFaculty AwardDr. Palmer is a former ClinicalProfessor and Associate Deanfor Professional Affairs at theSchool. He received his B.S.Pharmacy degree from theAlbany College of Pharmacyand his M.S., in 1960, andPh.D., in 1964, from theUniversity of Connecticut. Hejoined the faculty in 1958 as agraduate teaching assistant. Herose to the rank of ClinicalProfessor in 1981, was namedAssistant Dean in 1979 andAssociate Dean in 1985. He hashad a distinguished career as ateacher and has beenrecognized by his students andthe University as anoutstanding teacher. Dr. Palmerhas been active in state andnational pharmacy associationsand has been awarded the A.H. Robins Bowl of Hygeia forcommunity service, the SidneyA. Rome Award and the PaulPierpaoli Award of theConnecticut Society of HealthSystem Pharmacists. He is aPast President of theConnecticut PharmacistsAssociation.Dr. Peter FarinaHonorary PharmacyAlumni AssociationDr. Farina is Vice President,Development for BoehringerIngelheim Pharmaceuticals, Inc.He began his career at BI in1980 and has held variouspositions in the company. Hereceived his B.S. in 1967 fromHofstra University and hisPh.D. from SUNY College atBuffalo in organic chemistry in1971. He is member of theSchool’s Advisory Committeeand has been instrumental inobtaining BI support forresearch fellowships at theSchool and support for theCenter of PharmaceuticalProcessing. He also isresponsible for obtaining a$250,000 pledge to name thedosage form laboratory suite.Richard W. FooteHonorary PharmacyAlumni AssociationMr. Foote was a pioneer inenhancing the provision ofpharmacist care. He createdthe first patented multiplewarning label dispenser, thefirst copyrighted warning labelmessage with quick identitygraphic icons and the firstindustry-wide accepted drugchart which directly linked thedrug to specific warning labelmessages. Over the years, thecompany has expanded itsproducts to provide laserprinted patient informationsheets and other products toenhance the ability of thepharmacist to provideinformation to the patient.7

Honoring Philip Rosenberg and Steven CohenDozens of alumni and friendsof the Pharmacology/Toxicology Graduate Programreturned to campus on May19, 2004 for a celebrationcommemorating thedistinguished careers of Drs.Philip Rosenberg and StevenCohen. The Rosenberg/Cohen Symposium recognizedthe achievements andcontributions of these twoformer faculty members ofthe School of Pharmacy andthe many students whose livesthey touched along the way.During his 29-year career atUConn, Dr. Rosenberg servedas Head of the Pharmacologyand Toxicology Program. Healso helped create theinterdisciplinary Neurosciencesconcentration in 1982. In 1994,he became the first Head ofthe Department ofPharmaceutical Sciences, aposition he held until hisretirement in 1997. In additionto his outstanding leadership,Dr. Rosenberg is renowned forhis accomplishments inpharmacological research.He received the JavitsNeuroscience InvestigatorAward from the NationalInstitutes of Health in 1987, theDistinguished Alumnus Awardfrom Jefferson Medical Collegein 1989, and the University ofConnecticut Alumni AssociationAward for Research Excellencein 1990.Dr. Steven Cohen is anotherluminary in the School ofPharmacy. After joining theUniversity of Connecticut in1972, Dr. Cohen founded theToxicology Program and theCenter for BiochemicalToxicology, serving as directorfor both until 2000. Since1972, Dr. Cohen has receivedapproximately $5.5 million tofund his toxicology researchand training programs, includingthe renowned NIHEnvironmental ToxicologyTraining Grant. His researchgroup was given three “BestPublication of the Year” awardsfrom the Society of Toxicology.In 1997, he also received theUniversity of ConnecticutAlumni Association FacultyExcellence Award in ScientificResearch. He left the Universityin 2000, and is now the Chairof the Department ofPharmaceutical Sciences at theMassachusetts College ofPharmacy and Health Sciences -Worcester.The symposium celebratingthese two distinguishedscholars began with featuredspeaker Karl A. Nieforth, whoserved as the Dean of theSchool of Pharmacy from 1981-1993. This was followed bypresentations from alumni Drs.Cecelia Giambalvo, JeffFletcher, Marion Ehrich, andPhil Bartholomew.Distinguished researchers intheir own right, these scientistsand former students of Drs.Rosenberg and Cohen, spokeof their experiences and ofhow the inspiration andcounsel they received helpshape their careers.At the conclusion of theceremony, Dean McCarthyannounced the establishmentof the Philip Rosenberg andSteven D. Cohen GraduateFellowship in Pharmacology/Toxicology. This annual awardwill be given to an outstandinggraduate student in thePharmacology/ToxicologyPh.D. program who is involvedin rigorous research andscholarly productivity.Philip Rosenberg, with wife Sybil,[pictured at left] and StevenCohen, with wife Elaine, [picturedbelow] at the Rosenberg~CohenSymposium on May 19, 2004.

Pharmacy Leaders ConveneAlumni AssociationLife MembersIn May 2003, Dean RobertMcCarthy, consistent with theSchool’s central role infacilitating public policydiscourse, convened a groupcomposed of Connecticut’sleaders in pharmacy. Theinvitees agreed that this effortwould be a forum fordeveloping policy ideas andgathering information for theparticipants to take back totheir respective constituencies.From this initial meeting, theConnecticut PharmacyLeadership Group (CPLG) wasborn. The group will meetseveral times a year to discussissues of mutual interest and toidentify and promote areas ofcommon ground. Theorganizations currentlyrepresented in the CPLGinclude the School ofPharmacy, the School ofPharmacy Alumni Association,the Connecticut PharmacistsAssociation, the ConnecticutChapter of the AmericanSociety of ConsultantPharmacists, the ConnecticutSociety of Health-SystemPharmacists, and the Long-Term Care PharmacistsAssociation. Invitations havealso been extended to theConnecticut Commission ofPharmacy and the ConnecticutAssociation of Chain DrugStores.The mission of the CPLG is tofacilitate communication andcollaboration on major publicpolicy issues to achievelegislative goals that optimizemedication use throughpharmacist care. The CPLG iscurrently focused on topicssuch as collaborative practice,reimbursement for pharmacyservices, pharmacy technicians,the role of pharmacists inpublic health, drugdistribution, automation, andemergency preparedness.A pharmacy summit, focusingon patient safety and thepharmacist’s role, is planned forthe 2004-2005 academic year.Leaders from the State ofConnecticut’s executive andlegislative branches, as well asrelated government agencies,will be invited to participate.What’s New With You?We want to hear from you! Please use this form to tell us about address changes,personal and professional honors, or everyday events that we can use for the AlumniUpdate column. Mail To: University of Connecticut, School of Pharmacy AlumniAssociation, 372 Fairfield Road, Unit 2092 ~ Storrs, Connecticut 06269-2092, or e-mailus at: daniel.leone@uconn.eduMr. Mrs. Ms. OtherName:Class Year:Maiden/Former Name:Spouse Name:Address:City: State: Zip:Home Phone: ( ) Work Phone: ( )E-Mail Address:Employer/Business Name:Title:Business Address:City: State: Zip:News:9Welcome to the followingalumni joining as Life Membersin 2004.Selima Begum. Ph.D., ‘82Daniel D. Crosby, B.S., ‘88Thomas J. D’Amato B.S., ‘57Michael D. Greaves, B.S., ‘77Erin Halfpenny, B.S., ‘98Colleen Higgins, B.S., ‘98George F. Kirkpatrick Jr., B.S. ‘71Michael Lamson, Ph.D., ‘97Keith Lyke, B.S., ‘92Francesco Marini, B.S., ‘97Amy Martin, B.S., ‘96Bruce T. Moore, B.S., ‘75John A. Ohlund, B.S., ‘76Capt. Daniel Raboin, Pharm.D., ‘02David L. Rosen, B.S., ‘78Jill Nicholson Sackett, B.S., ‘81Edward J Sklanka, B.S., ‘74Kathleen M. Snow, B.S., ‘78Mohammed Yusuf, M.S., ‘76In MemoriamRonald L. Jacoby PhD ‘71September 30, 2002Arthur Zucker ‘65April 6, 2003James J. Agro ‘61December 25, 2003Thomas J. Macura ‘71March 15, 2004John H. Sullivan ‘53March 26, 2004John W. Harold ‘79July 18, 2004Pamela A. (Peck) Chambers ‘93September 8, 2004Theodore V. Stawicki, Jr. ‘70September 29, 2004

New ScholarshipEndowmentsJames M. FaucetteMemorial ScholarshipJerry and Babs WeitzmanMemorial ScholarshipJohn L. O’BrienMemorial EndowedScholarship FundGreater BridgeportPharmaceutical Association, Inc.Scholarship FundKarl A. and Joan C. NieforthPharmacy Student ScholarshipAngelo DeFazioEndowed Scholarship FundJoseph C. Papa, Sr.Endowed Scholarship FundDepartment of PharmaceuticalSciences Graduate AwardSchool of Pharmacy Exceeds Goals Under Campaign UConnCampaign UConn, the six-year$300 million private fundraisingeffort to support thepeople and programs of theUniversity, concludedsuccessfully on June 30, 2004with a total of $471.1 million innew gifts and commitments. Aspart of the Campaign, theSchool of Pharmacy raised$6.23 million through itsBuilding a Future for PharmacyTogether endeavor, exceedingthe $5 million goal by 25%. Ofthis amount, nearly $2.2 millionwas raised for faculty support,$900,000 for student support,and $3.1 million for programsupport.Moreover, in the final year ofthe Campaign, commitmentsskyrocketed from $400,000 in2001 to $3.15 million in 2004,or fully half of the $6.23million total. As a result of theCampaign the School’s totalendowment now stands at $4.2million.The Campaign’s success has ledto the establishment of 12 newendowment funds to benefitstudents, faculty, and programswithin the School. In additionto the Pfizer DistinguishedChair, the Marlene L. Cohenand Jerome H. Fleisch Fund inPharmaceutical Sciences wascreated to support faculty inthat department. The Dean’sAdvancement Fund for theSchool of Pharmacy and theSchool of PharmacyEndowment for the 21stCentury are two newly createdendowments for programenhancements. In addition,eight, new, endowedscholarships were funded bygenerous alumni and otherdonors [see inset].Dean Robert McCarthysummed up the School’s fundraisingsuccess, “Private supporthas transformed the School ofPharmacy and opened manyeyes to the quality of ourinstitution nationally. Theoverall impact of the gifts wereceived will also enable us tocomplete a number of strategicobjectives as we plan for 2005and beyond. We’re exceedinglygrateful to everyone whostepped forward to expressfaith in the work we aredoing.”ThankDeborah Faucette ’80, vicechair of the School ofPharmacy Advisory Board, whoestablished a scholarshipendowment in her brother’sname, talked about the impactof the Campaign and theimportance of giving something10back to UConn. “No matterwhere our profession has takenus, all alumni are proud to saywe are graduates of theUConn School of Pharmacy.Providing a gift to the Schoolto benefit others serves as agreat vehicle to celebrate thatpride and honor loved ones.”Under the School of PharmacyEndowment for the 21stCentury, $1.2 million has beendonated for 25 of the namedspaces in the School’s newhome, slated to open in the fallof 2005.Private support continues to bea critical component of theSchool of Pharmacy’s goal ofbecoming a Top 10, nationallyrecognized institution. Formore information aboutsupporting scholarships, facultyresearch, and programs in theSchool, contact BrianLachapelle, Director ofDevelopment at 800-269-9965orblachapelle@foundation.uconn.edu.Many Thanks to all who supported$1,000,000 and upPfizer, Inc.$200,000 to $999,999Boehringer IngelheimPharmaceuticals, Inc.Samuel S. ‘61 and Virginia S.KalmanowitzDave ‘61 and Brenda M. ‘61 Roth$100,000 to $199,999Neil Alan and Franciene-AlexaLehmann ‘89Breckenridge Pharmaceutical, Inc.CVS CorporationWilliam M. ‘65 and Sharon HaitJohnson & JohnsonLaurence D. Runsdorf ‘61Joseph A. Morosko ‘52*Joseph ‘78 and Nancy Papa$50,000 to $99,999UConn School of PharmacyAlumni AssociationArthritis Foundation, Inc.Baxter Health Care CorporationAngelo DeFazio ‘85Dow Chemical CompanyJerome H. Fleisch and Marlene L.Cohen ‘68Genzyme Corp.Gerald N. ‘60 and Petrina KoblinLavipharm Laboratories, Inc.Robert Leet & Clara GuthriePatterson TrustEli Lilly & Co.Mark M. ‘63* and Ruth* LuckensOrtho-McNeil PharmaceuticalYvette PergolaMonty Schwartz ‘66Edward N. ‘49 and Evelyn SilverWalgreen Company

Campaign UConn ~ especially the following Major Contributors…$25,000 to $49,999American Chemistry CouncilAmerican Federation for AgingResearch, Inc.Deborah J. Faucette ‘80Andy and Mary O. GalardiGreater Bridgeport PharmaceuticalAssociation of Connecticut, Inc.Juvenile Diabetes FoundationMerck & Co., Inc.Edward* and Edith* MogullPeter ‘55 and Jeannette T. SciannaStyrene Information and ResearchCenterYou$2,500 to $24,999Bayer Corp.Maurice ‘57 and Mary BeaulacDavid ‘67 ’71 and Nancy ‘67 BloisBrooks PharmacyJohn A. Capuano ‘73 ‘02Richard T. Carbray, Jr. ‘75 andPatricia A. CarbrayJennifer S. Chase ‘91Connecticut PharmacistsAssociationCVS CorporationDesignwrite IncorporatedStephen ‘72 and Sharon ‘72 EnrightJacqueline M. Murphy ‘78 andBrian S. GordonMargherita Guiliano ‘75Barbara Haber ‘59Hannaford Brothers Co.Cynthia E. Huge ‘75Joyce F. JacksonJohn A. Kiszkiel II ‘75Daniel ‘53 and Maryanne ‘59 LeoneMaxi Drug South, LPRobert L. and Maureen McCarthyGordon ‘52 and Rita ‘52 McGuireNCS Healthcare of OhioStuart D. ‘70 and Sharon NeissKarl A. and Joan C. NieforthWilliam E. and Carol L. OliverAnthony S. Ozga*Henry ‘60 ‘65 and Janice PalmerJoseph ‘73 ‘81 and Lorraine PaloMichael J. and Janice L. PikalRobert ‘66 and Joyce ‘66 PincoPricewaterhouseCoopersFoundationThe Procter & Gamble CompanyRite Aid CorporationJoseph L. Sewall ‘30*The Stop & Shop CompanyPatricia A. Toce ‘75 ‘93Alan D. Traster ‘71Lawrence V. Traster ‘75Varro E. Tyler, Jr. ‘51 ‘53 ‘98H*Virginia M. TylerVinyl Acetate Toxicology Group,Inc.$1,000 to $2,499Alliance Capital ManagementApex Pharmacy & Home CareCenterKaren P. Arledge ‘65AstraZenecaAventis Pharmaceuticals, Inc.Bella Vista Pharmacy & SurgicalSupplies, Inc.Joel S. and Robin H. BognerPeter and Lorraine ‘76 BuerhausBristol Myers Squibb CompanyJane G. BurtCardinal HealthGeorge H. Cocolas ‘52Kenneth A. Connors ‘54Anita P. Denly ‘66Barbara H. Deptula ‘78Eric ‘95 and Stefanie ‘97 FerreriGregory G. Gawlick ‘73Charles J. Grannick ‘66Mark Hirsch and Jane Hirsh ‘65Hayden O. Houston, Jr. ‘72International Business MachinesCorp.James A. Langone ‘72 andTheresa M. GuiribiteyCharles Lewis Beach SocietyThe Charles Lewis BeachSociety honors the manyindividuals that support theUniversity through will, trust,retirement plan and lifeinsurance gifts. The Societyalso honors donors who makegifts that will enhance their ora loved one’s financialposition, and ultimatelysupport the School ofPharmacy’s initiatives.A teacher and researcher in dairy production, Charles Lewis Beachwas asked to husband the resources of the ConnecticutAgriculture College in 1908. In 1933, President Beach established afund through his will to honor the memory of his wife, LouiseCrombie Beach, and provide enduring support to the University.Please join Harry and Selma Swatsburg and the 700 members ofthe Charles Lewis Beach Society University-wide whose gifts ensureexcellence for the future.To advise the School of Pharmacy about your gift, or to requestconfidential information about will, trust, retirement, life insurance,or income-enhancing plans, please contact Peter McAvoy, JD at(800) 269-9965, or pmcavoy@foundation.uconn.edu.Robert J. Lewandowski ‘71Eli Lilly & Co.Bruce S. and Loretta L. McCabeMcNeil Consumer & SpecialPharmaceuticalMerck & Co., Inc.Alan J. ‘65 ‘68 and Nancy K. ‘67‘77 MilbauerJames W. Munden ‘72NACDS FoundationNicholas A. Olimpio ‘67Olin CorporationPAFPS, Inc.Parkade Health Shoppe, Inc.Erica Peitler ‘88Princeton Partners, Inc.Stephen M. Sanditz ‘75Marie A. Smith ‘77Harry ‘49 and Selma SwatsburgSergio F. Toni, Jr. ‘’80 andChristine ToniWayne L. Tomsky ‘67*Deceased“Tell me and I’ll forget.Show me and I’ll remember.Involve me and I’llunderstand.”A favorite quote of Harry Swatsburg.Married 62 years, Harryand Selma Swatsburg wantto repay “the good that hascome to them.” Both wereborn in the heart of thedepression and grew upnext door to each other inNorwich, CT. The couplemarried during WWII whenHarry was on furlough. Itwas during his service as anAir Force PharmacyTechnician that he decidedto pursue a career inpharmacy after the war. In1950, the couple opened theUncas Pharmacy in Taftville,CT. “We built our businessby reserving copies of theSunday newspaper for ourcustomers,” says Harry.This commitment to servicepervades their lives. Harryhelped to establish the firstpre-school program inNorwich, CT, sat on thepension board for the town,and is committed to helpingstudents through theestablishment of ascholarship fund. Thecouple are members of theCharles Lewis Beach Society.

Pfizer Gift Establishes Distinguished Endowed Chair in Pharmaceutical TechnologyPfizer Global Research andDevelopment, the R&D divisionof Pfizer, Inc. and the world’slargest private biomedicalresearch organization, has madea $2,000,000 gift to endow adistinguished chair in theSchool of Pharmacy. It is thelargest single gift ever receivedby the School and its firstendowed faculty position.The academic appointment,which will focus onpharmaceutical technology inthe department ofPharmaceutical Sciences, is oneof just four distinguishedendowed chairs at theUniversity. It will enable theSchool of Pharmacy to appointa nationally recognizedresearcher, scholar and teacherwho has made significantcontributions to the field.Pharmaceutical technology, theapplied science for dosageform development, is builtupon a foundation of thephysical and engineeringsciences. It addresses productdevelopment requirements fordiverse medicinal agents, andalso encompasses the physicaland engineering sciences ofPfizer representatives at the announcement of thePfizer Distinguished Endowed Chair in Pharmaceutical Technologydrug delivery by means ofmultiple routes, including oraland parenteral.Professor Michael Pikal, amember of the PharmaceuticalSciences faculty, says, “ThePfizer Distinguished EndowedChair brings prestige andfinancial resources to thePharmaceutical Technologyprogram at UConn. This willinsure continued excellence inthe School of Pharmacy andallow expansion of the UConnprogram as well ascollaborations between Pfizerand UConn. It will alsopromote this critical R&D areathroughout the rest of thecountry.”Pfizer, Inc. has previouslyendowed faculty positions atStanford University and DukeUniversity, but this is the firstsuch gift by the company to aSchool of Pharmacy in theUnited States.“Pharmaceutical sciencesresearchers play a key role inthe discovery and developmentof new medicines for patientsin need,” notes Kelvin Cooper,head of Pfizer Global Researchand Development’sPharmaceutical Sciencesorganization. “In today’scompetitive recruitingenvironment, Pfizer mustattract the best and brightestscientists in order to find curesfor diseases like Alzheimer’s,cancer and diabetes. We areproud to partner with UConn’sSchool of Pharmacy, andcontinue to look to theirprogram as source of qualifiedresearchers who will help usachieve our mission of doingmore good for more peoplethan any other company in theworld.”Proceeds from the endowmentwill support the PfizerDistinguished Chair in his orher academic activities,including pre- and postdoctoralgraduate fellowshipsand a PharmaceuticalTechnology Symposium.“The establishment of thePfizer Distinguished EndowedChair in PharmaceuticalTechnology is one of the mostsignificant events in the nearlyeighty-year history of theSchool of Pharmacy,” saysDean Robert L. McCarthy.“Great schools and colleges ofpharmacy are able to establishendowed chairs to attract thebest teachers and scholars totheir campus. Pfizer’s gift willallow us to join this elite groupof institutions. We are mostgrateful for their confidence inus.”The School will initiate anational search to identifycandidates that is expected toconclude in spring 2005.12Photos at Right: School of Pharmacy graduate students look on as Pfizerannounces its gift on June 23, 2004 (Top); Professor Michael Pikal, Dr.Tim Hagan, Vice President of Science & Technology at Pfizer, and DeanRobert McCarthy (Bottom Left); Graduate Student, Sandra Goss, KelvinCooper, Senior VP for Worldwide Pharmaceutical Sciences at Pfizer, andUConn President Philip Austin celebrate the occasion (Bottom Right.)

The Pfizer Distinguished Endowed Chair will Support Research, Scholarship, and Teaching

GraduatesSarah AliceaAmy BachyryczRyan BangTrinh BuPaul BukowskiAnnik CarrierElizabeth ChaseXiaoLi (Sueli) ChenGrace ChonJennifer ClaymanBryan CretellaKelly DaigleNancy DaigleGeorge delCampoAlicia DesiletsChau My DoanCarl EngmannBessem EnohJohn FlorentinoCharles FreelandMarlon FullerKevin GatlandAmanda GilbertRosalba GugliottiThomas HiteKaren HoangIdongesit IdiongAlexandra IgoumenosDoctor of Pharmacy (Pharm.D.)Class of 2004Jason JefferyElizabeth JohnstonAngeliki KarapanosFrancis KissiAgnes KrudyszRahul KumarLynn LamotheNicholas LaRiviereMicky LatinaJennifer LeeKaren LemonsHaley LeoneErin LewisPaul LukomskiAllison MayPatrick McMahonYolanda ModzelewskiJanell MoralesJohn MoyherMichael MuldoonSandra NarineJuliette NguyenThientu NguyenMichael O’KeefeAndrea PearyBrian PelletierKaren PickelGrazyna RiebandtDoctor of Pharmacy(continued)Jeff RyanZohra SalehiSamuel SallingRadhika SaneAbishag SarkodieMatthew SicotteMichelle SilvayVinnita SinhaJohn SkinnonSokhak SoXiao Ying (Shannon) SongElizabeth St. LouisAlec TheisArthur TiptonGrace TongNgoc-Bich TranChristine TullyEfthimia VasiliadisRyan VasquezMelissa WalczykDavid WuChristopher ZajacCynthia Mei Feng ZhangPictures:School of Pharmacy B.S. graduatesat the May 2004 Commencementceremony [Top Left]. Members ofthe Class of 1979 enjoy theirreunion [Near Right]. AssociateProfessor, Robin Bogner, leads theClass of 2004 to Gampel Pavilionfor the May 2004 Commencement[Far Right].14Doctor of PhilosphyClass of 2004Liu-Quan Chang, Ph.D.Linda Marie Chicoine, Ph.D.George John Dimopoulos, Ph.D.Jianxin Guo, Ph.D.Chonghua Li, Ph.D.Dadong Li, Ph.D.Shailaja Rambhatla, Ph.D.Vikas Kumar Sharma, Ph.D.Xiaolin Tang, Ph.D.Michael Scott Thibodeau, Ph.D.Master of ScienceClass of 2004Sarah Mowbray, M.S.

Bachelor of Science in Pharmacy StudiesClass of 2004Awadelkarim M. AhmedNicholas J. AmbrosinoKenneth A. AngleJeffrey K. AtkinsonMaria C. AugelloMarie M. AyoubJill A. BarberSarabeth BaxterDavid R. BobeckDanielle M. BoschettoTammy M. BrennanCheri A. BrisboisKelly A. BroadBrandon E. BrodeurJeffrey M. BurgessGregory M. BurkmanTiffany L. CastelliJulie Yong Ju ChenTiffany K. CollinsPatrick F. CorbettAmy N. CordnerDavid L. CrosbyDanielle M. DesjardinsHeather A. DoigCourtney J. DoyleRyan P. DuffWayne H. Eastman IIIKeri L. EganJennifer M. FitchKathryn M. FoleyCarol B. FoxRyan C. FrostAndy T. FuRachel L. GalvanThomas W. GarbariniLukas D. GilmoreZoe GlarasNicole M. GuarrasiKeith Hughes, Jr.Lauren N. IppolitoDouglas H. JackensBekim JashanicaAndrew R. KovacsJill M. LacasseOlivia C. LauAnnette M. LipinskiSteven LucianoS. Elizabeth LuciniLaura B. LuciveroBryan S. MarinasSherry-ann R. MarshallJohn M. McBrideSarah M. McCabeDerek J. McFerranNigjar MemetiAmina M. MohamedMeghan E. MonsD’Ana M. MontanezJoseph R. MorasuttiHsiao Yen A. MorrisonSean M. NortonAsamoah OtengElizabeth C. PalilloLopa H. PandyaJignashu A. ParikhSarah K. PerraultGelson PizarroChristopher D. PludeChad E. PorterfieldKarlie A. PowerMichael A. RiveccioAngelique M. RovaldiLauren M. RussoArpan A. ShahKatherine M. SheaDavid S. ShepherdDevon-Anne SherwoodKara L. SmithSokpoleak SoRobert A. SouthardKatherine M. StaffordAdam C.T. SullivanDavid H. TranWanchen TsaoStephanie A. TsouvalasLogan E. VasinaWilliam B. WhittakerPeter T. Zoob

Student NewsSarah McCabe, PresidentUConn Chapter APhA-ASPThe pharmacy professionaffords students manyopportunities to network withcolleagues and to gain handson experience in the field tobetter prepare for successfulcareers. The University ofConnecticut’s AmericanPharmacists Association,Academy of StudentPharmacists (APhA-ASP) assistsin providing manyopportunities that enhance thepharmacy education of itsmembers.StudentsIn March, the UConn ChapterAPhA-ASP was thrilled tobring twenty-two of itsmembers to attend the APhAAnnual Meeting in Seattle,Washington; our second largestgroup to attend the AnnualMeeting! Through the supportof the Undergraduate StudentUConn Chapter APhA-ASPGovernment (USG) at UConn,and our successful LL Beanfleece fund-raiser, the groupcovered all of the costs for themembers to attend themeeting. These students wereable to learn more about theprofession of pharmacy byattending meetings andnetworking with futurecolleagues and employers. Inaddition to attending meetings,students actively campaignedfor former APhA-ASP ChapterPresident, Rachel Sykes, as sheran for APhA-ASP NationalMember At Large. Althoughshe was not elected to theposition, she provided anexcellent example to theChapter’s younger members totake on a leadership role.The UConn APhA-ASPChapter held OperationDiabetes at Rite Aid Pharmacyin Enfield, Connecticut toprovide its members withpractical, hands-on experience.During the clinic, students wereable to interact with patientsby taking their medicalhistories and blood pressure,explaining the results ofglucose tests, anddemonstrating how to properlyuse a glucose meter.Members of our chaptercontinued to pursue learningopportunities during thesummer months. This pastJune, for example, I was giventhe opportunity to attend the53rd Annual University ofUtah School on Alcoholismand Other Drug Dependenciesin Salt Lake City, Utah. InJuly, the UConn APhA-ASPChapter sent Kate Dziedzic, theMembership Vice President(MVP) to the APhA-ASPSummer Leadership Institute inWashington, DC. Thisexperience helped to prepareKate for her responsibilities asMVP, while helping her tofine-tune her leadership skills.The Chapter also gratefullyacknowledges Dean McCarthyand our Advisor, Dr. JoséManautou, whose invaluablesupport has contributed to oursuccess.Liz Palillo, First PresidentPharmacy Student GovernmentChange has become part of thedaily routine as the Universityof Connecticut heads into the21 st century. The School ofPharmacy is no exception.With new faculty members, anew building in the upcomingmonths and, now, a newstudent organization, change isa welcome part of thepharmacy community.A new student organization,the Pharmacy StudentGovernment (PSG,) has beencreated with the help ofAssociate Dean Speranza andseven other students. Aconstitution was written andelections were implementedduring the spring semester,which allowed the organizationto function in time for thecurrent academic year.Pharmacy Student GovernmentThe purpose of theorganization is to unite thestudent body and to increasespirit and morale. Membershipincludes representatives fromall of the other pharmacystudent organizations, as wellas members from each class.There are over 30 enthusiasticmembers, including newlyelected P1 students. Theorganization is fortunate tohave dedicated P4 studentscommuting to meetings fromtheir rotation sites.Meetings are occurring on aregular basis and great thingsare being planned for thefuture. A major undertakingwill be the School of PharmacyFormal planned for April2005. It will be anopportunity for students,faculty, and staff to spend timetogether outside the classroomenjoying dinner and dancing.Monthly spirit events, such asfree coffee and muffins, areplanned for each class. Thegoal is to build a strongorganization that can lead ourstudent body towards a futurein pharmacy.

Public School PartnershipSandy Goss, PresidentUConn Student Chapter AAPSThe University of Connecticutstudent chapter of theAmerican Association ofPharmaceutical Scientists(AAPS) 2003-2004, continuedto provide members withcareer advancementopportunities and insight intotechnical issues pertaining tothe pharmaceutical field. Thechapter also tried to instill asense of community amongthe graduate students. Theexecutive committee completedthe construction of its website,www.pharmacy.uconn.edu/AAPS. The site is updatedregularly to reflect newactivities.In the fall of 2003, the studentchapter co-sponsored aluncheon with Dean RobertMcCarthy to welcome allUConn Student Chapter AAPSincoming graduate studentsinto the department. Ourorganization has beenfortunate to always have thepersonal, as well as financial,support of Dr. McCarthy forAAPS student events.Members from the NationalAAPS student affairs officejoined us in spring 2004 andwere very impressed with theparticipation of all studentchapter members and ourfaculty advisor, Dr. DevendraKalonia. We learnedtechniques to increasemembership by reaching out tostudents in related fields suchas chemistry and engineering,which also play an importantrole in pharmaceutical sciences.Later that spring, a speakerfrom Pfizer, Dr. EvgenyiShalaev, presented a seminarentitled “The concept of‘structure’ in amorphous solidsfrom the perspective of thepharmaceutical sciences.” Thisis an important topic related tomany research projects withinthe department. The AAPSstudent chapter also hostedmock industrial interviews withDr. Galen Radenbaugh fromSchering-Plough ResearchInstitute in New Jersey toimprove students’ interviewingskills for positions in thepharmaceutical industry. In thefuture, we hope to furtherprepare ourselves for careersafter graduate school andincrease quality membership inwhich the School of Pharmacycan take pride.Last year, the School ofPharmacy formed a partnershipwith the New Haven PublicSchool System for the purposeof influencing minoritystudents to pursue a career inpharmacy. The genesis of thisprogram is due to the effortsof Dr. Marlon Fuller, a 2004graduate of the School. Dr.Fuller is an African-Americanwho is committed to serving asa role model for minority highschool students fromdisadvantaged backgrounds.The initial effort of thepartnership consisted ofconducting several high schoolassemblies in New Haven, CT.These programs exposedstudents to pharmacy as acareer and providedinformation about how toprepare to study pharmacy atthe University of Connecticut.Selected students visited theUConn campus andparticipated in a presentation inthe School of Pharmacy thatfocused on the pre-pharmacyand professional academicprograms, career opportunitiesin pharmacy, and Universityprograms and services forminority students.Following the presentation,students toured the campus,visiting the Homer BabbidgeLibrary, Gampel Pavilion, theUConn Co-op and a modeldorm room. Students weretreated to lunch in theNorthwest Dining Hall.During the 2004-2005academic year, Walgreens willjoin the partnership to help todevelop a communitypharmacy shadow programthat will expose students to thedaily activities of thecommunity pharmacist. Oncethe community pharmacyshadow program is successfullyimplemented, it will beexpanded to the hospitalpharmacy setting. To reinforcethese shadowing experiences,UConn pharmacy students willserve as mentors for students.Future goals of the partnershipinclude developing a workassistance program incooperation with localcommunity and hospitalpharmacies and developing aneducational support system atthe University and School ofPharmacy that enhancesminority students’ ability tosuccessfully complete theprofessional program.Cooperative efforts andeducational experiences, suchas this program, enable theSchool of Pharmacy to providethe citizens of this state withpharmacists who are trulyrepresentative of thepopulation served.17

Teaching & LearningPharmacy Education Management SystemCurriculum Committee 2003 - 2004Dr. Andrea K. HubbardCo-chair Curriculum CommitteeIn the fall of 2002, DeanMcCarthy charged the School ofPharmacy CurriculumCommittee to “complete a zerobasedreview of the professional,Pharm.D., curriculum” and“recommended a revisedcurriculum be submitted to thefaculty” for their approval. Inthe spring of 2003, theCurriculum Committeeproposed and received facultyapproval for new CurriculumCommittee by-laws and alsodeveloped a new curriculummission statement. TheCurriculum Committee thendrafted educationalcompetencies and outcomeexpectations for our students.Dr. Philip HritckoDirector of Experiential EducationIn spring 2004, the Office ofExperiential Education at theUniversity of ConnecticutSchool of Pharmacy implementedan online rotation managementsystem. The system, known asthe Pharmacy EducationManagement System (PEMS),was created by ROI SolutionsGroup, Inc. to assist schools ofpharmacy control theirAdvanced Practice Experience(APE) rotations for P4 students.ImprovingIn the fall of 2003, theCommittee accepted theeducational outcomes documentthat was subsequently presentedto the School faculty andunanimously approved. TheCurriculum Committee thenbegan the process of mappingthe current curriculum to meetthese outcomes. From this map,Dr. Sean JefferyCo-chair Curriculum Committeethe Curriculum Committeenoted fluctuations in theemphasis of specific outcomesand in the sequence of certaincourses. Foundational sciences,for example, are stronglyemphasized in the P1 year anddecline over the next threeyears. Drug information andpharmacotherapy graduallyincrease in emphasis over theP1-P4 years of the professionalprogram. These findings led tochanges in the programcurriculum. The currentimmunology course, forexample, will now include abiotechnology component andbe placed in the P1 year as afoundational course. TheCurriculum Committee alsorequested handouts andlearning objectives from facultywith the intent of determiningredundancies or gaps in thecurrent curriculum.In May 2004, the CurriculumCommittee and the AssessmentCommittee met for a day-longretreat and drafted a newcurriculum with the followingproposed changes:· increasing flexibility inscheduling,· adding anatomy & physiologyas a prerequisite course,· increasing professionalelectives from 12 to 15 credits· integrating pharmacology,medicinal chemistry, nonprescriptionmedication,clinical pharmacokinetics andtherapeutics into organ-basedmodules,· adding 16 credits of newcourse material to includeclinical toxicology and adermatology based module,· adding a course in correlatedpharmacy problem solvingthat is case based and stressesapplication of didactic material.During the fall of 2004, severalspecial “Faculty Town HallMeetings” were scheduled tobe held to discuss coursecontent, credits and sequencingof the new proposedcurriculum, as well as possiblechanges in the prerequisitecourses. During this time, theCurriculum Committee willwork closely with theAssessment Committee andanalyze survey responses andinput from students, alumniand preceptors.Faculty approval of the newcurriculum is targeted for theend of the 2004 calendar year.18PEMS is a dynamic, highlycustomizable, rotationmanagement software packagewith many unique features.Rotation management is thecore of this system, but thesystem is flexible enough toaccommodate changingrequirements. Using PEMS,customized schedules arecreated, assigned, and modifiedto meet pharmacy students’educational needs.This system has increased theefficiency of the Office ofExperiential Education byreducing the time spent onscheduling and allowing an easymeans of communication withpreceptors and students. Italso provides the addedfunction of a data warehouseto compile and maintainstudent records and create andgenerate reports.PEMS allows preceptors toview site rotation schedules,maintain a list of all students,enter evaluations, reviewattendance, send e-mail tostudents, and readannouncements and messageswhile online. Students havethe ability to researchpreceptors and rotation sitesby viewing specific rotationcourse syllabi and traveldirections to the sites throughthis system. The students alsohave the ability to completeonline evaluations, view theirevaluations, and receivemessages and announcements.These are just a few of themany features offered by thismanagement system. TheOffice of ExperientialEducation plans to enhanceand update the system asnecessary to meet the needs ofstudents, preceptors, and theSchool of Pharmacy.

Advisory BoardNew FacultyMichele BelseyVice President of College Relations &Professional RecruitmentRite Aid CorporationLydia J. BorysiukChief of PharmacyVA Connecticut Healthcare SystemRichard T. Carbray ‘75OwnerApex PharmacyAngelo DeFazio ‘85PresidentArrow PharmacyJoseph E. DeLucia ‘65Executive DirectorNCS Health CarePeter Farina, Ph.D.Vice President of DevelopmentBoehringer Ingelheim PharmaceuticalsDeborah Faucette ‘80, Vice ChairDirector of Pharmacy OperationsNACDSJean Paul Gagnon ‘63Director of Public PolicySanofi-AventisGregory Gousse ‘71Director of PharmacyHartford HospitalMargherita Guiliano, ‘75Executive Vice PresidentConnecticut Pharmacists AssociationTim Hagen, Ph.D.Vice President of PharmaceuticalResearch and DevelopmentPfizerC. Daniel HaronVice President of Pharmacy andProfessional AffairsBrooks PharmacyMichael T. Heffernan, ‘87PrinicpalCollegium PharmaceuticalSamuel S. Kalmanowitz, ‘61Lucinda L. Maine, Ph.D.Executive Vice PresidentAmerican Assoc. of Colleges of PharmacyCarlos R. OrtizVice President and Director ofGovernment RelationsCVSJoseph D. Palo, ‘73PartnerBusiness Consulting ServicesIBM Global ServicesJoseph C. Papa ‘78, ChairPresident and Chief Operating OfficerWatson PharmaceuticalsRobert Pinco, J.D. ‘66Senior CounselBuchanan & IngersollCharlene Polino ‘81President and Chief Executive OfficerSecure Source, Inc.Elliott D. Tertes ‘62Chairman, Board of TrusteesAmerican Society Consultant Pharmacists,Research and Education FoundationEx-Officio MembersBrian LachapelleUniversity of Connecticut FoundationRobert McCarthy, Ph.D.Dean, School of PharmacyFaculty and Student MembersRobin Bogner, Ph.D.Associate ProfessorDennis J. Chapron, ‘71Associate ProfessorRonald Langner, Ph.D.ProfessorKara UlizioIdongesit IdiongDr. Kevin Chamberlin Dr. Lauren Schlesselman Dr. Olga VinogradovaKevin Chamberlin, Pharm. D.,joined the University ofConnecticut School ofPharmacy as an AssistantClinical Professor of InternalMedicine and Geriatrics. Analumnus, Dr. Chamberlin beganhis career managing complexpharmacotherapy regimens as aGeriatric Pharmacy SpecialtyResident at the VAConnecticut Healthcare System.He became a member of theAmerican Society ofConsultant Pharmacists, and isalso an Editorial Assistant withthe Geriatric Pharmacy Review.Dr. Chamberlin received theAPhA Mortar and PestleProfessionalism Award in 2003.Currently based at the UConnHealth Center in Farmington,CT, Dr. Chamberlin’s researchinterests are focused ingeriatrics, particularly painmanagement, wound care, anddrug-related problems withinthe elderly population.Lauren Schlesselman, Pharm.D.,joined the University ofConnecticut School ofPharmacy as an AssistantClinical Professor of PharmacyPractice. An alumna, Dr.Schlesselman obtained herDoctorate of Pharmacy at theUniversity of Georgia in 1998.After completing a specialtyresidency in Adult InternalMedicine in Gainesville, FL, shereturned to Georgia, where shewas named “Young Pharmacistof the Year” by the GeorgiaSociety of Health-SystemPharmacists.Dr. Schlesselman is also a freelancewriter for several medicaljournals, including DiPiro’sPharmacotherapy, theEncyclopedia of ClinicalPharmacy, and a monthlycolumn in the Pharmacy Times.She has been published andreviewed for various pharmacyjournals and websites.Olga Vinogradova, Ph.D.,joined the School of Pharmacyfaculty as an AssistantProfessor of MedicinalChemistry. She received hermaster’s degree at the MoscowInstitute of Physics andTechnology, and her doctorateat Case Western ReserveUniversity. In addition, Dr.Vinogradova was a PostdoctoralResearch Fellow at theCleveland Clinic Foundation.Dr. Vinogradova has receivednumerous honors, among themthe NIH Research FellowshipAward, the Lerner ResearchFellowship Award, and theAHA Scientist DevelopmentGrant. She is also an ad hocgrant reviewer for the NationalScience Foundation and theHealth Research Board inIreland.

Focus on FacultyFaculty PublicationsDepartment of Pharmaceutical ScienceDennis J. ChapronAssociate ProfessorIn 1996, the University ofConnecticut’s School ofPharmacy was chosen by theAmerican Society ofConsultant Pharmacists (ASCP)to establish a trainee program.Over the past decade, theASCP has established sevensuch programs for outstandingpharmacy schools nationwide.Because of the School’snationally recognized faculty, aswell as our teaching andresearch programs in geriatrics,the ASCP has provided aPharmacotherapy traineeshipthrough grants provided bypharmaceutical companies.Faculty for this intensive, fivedayprogram were chosen fromthe School of Pharmacy, theUniversity’s Center on Aging,and the Hebrew Home andHospital, all of which havedeveloped strong teaching andfellowship programs forASCP Training Programpharmacy students. Traineesare chosen from a nationalpool of applicants that is highlycompetitive. As of 2003, 108pharmacists have completed theDisease Pharmacotherapytraineeship.While in the program, traineeslearn through both anexperiential component, whichinvolves a variety of directpatient care activities, and adidactic component, which istaught by nationally recognizedclinicians. The traineeshipfocuses on several areas,including disease managementof heart failure, osteoporosisand osteoarthritis in elderlypatients, patient interviewingskills, physical and cognitiveassessment, and theprioritization of problems inpatients with polymorbidities.Students also learn the use ofpoetry in the medical setting,not only for enhancing clinicalinsight, but for developing atrue compassion for theexperience of aging with illness.The traineeship is coordinatedby Henry Schneiderman of theHebrew Home and Hospitaland by Dennis Chapron andJohn Folstad of the School ofPharmacy, who also act aspreceptors for the program.BRIAN J. ANESKIEVICHCiarlo, J. D., Flores, A.M., McHugh, N.G. &Aneskievich, B.J. (2004). FHL2 expression inkeratinocytes and transcriptional effect on PPARa/RXRa. Journal of Dermatological Science, 35:61-63.Flores, A. M., Li, L. & Aneskievich, B. J. (2004).Isolation and functional analysis of a keratinocytederived,ligand-regulated nuclear receptorcomodulator. Manuscript submitted to the Journalof Investigative Dermatology.BEN A. BAHRBahr, B. A. (2003). Dysfunction and activation of thelysosomal system: Implications for and againstAlzheimer’s disease. Focus on Alzheimer’s DiseaseResearch, 115-150.Ekdahl, C.T., Mohapel, P., Weber, E., Bahr, B.,Blomgren, K., & Lindvall, O. (2003). Caspasemediateddeath of newly formed neurons in theadult rat dentate gyrus following status epilepticus.European Journal of Neuroscience, 16:1463-1471.Bendiske, J., & Bahr, B. A. (2003). Lysosomalactivation is a compensatory response againstprotein accumulation and associatedsynaptopathogenesis – An approach for slowingAlzheimer’s disease? Journal of Neuropathology andExperimental Neurology, 62:451–463.Ferrand-Drake, M., Zhu, C., Gidö, G., Hansen, A.,Karlsson, J-O., Bahr, B. A., Zamzami, N., Kroemer,G., Chan, P., Wieloch, T., & Blomgren, K. (2003).Cyclosporin A prevents calpain activation despiteincreased intracellular calcium concentrations, as wellas translocation of apoptosis-inducing factor,cytochrome c, and caspase-3 activation in neuronsexposed to transient hypoglycemia. Journal ofNeurochemistry, 85:1431-1442.Emgard, M., Hallin, U., Karlsson, J., Bahr, B.A.,Brundin, P., & Blomgren, K. (2003). Both apoptosisand necrosis occur early after intracerebral graftingof ventral mesencephalic tissue: A role for proteaseactivation. Journal of Neurochemistry, 86:1223-1232.Ekdahl, C.T., Zhu, C., Bonde, S., Bahr, B.A.,Blomgren, K., & Lindvall, O. (2003). Deathmechanisms in status epilepticus-generated neuronsand effects of additional seizures on their survival.Neurobiological Discoveries, 14:513-523.MARLENE BOUVIERFrickel, E., Frei, P., Bouvier, M., Stafford, W.,Helenius, A., Glockshuber, R. & Ellgaard, L. (2004).ERp57 is a multi-functional thiol-disulfide oxidoreductase.Journal of Biological Chemistry, 279:18277-18287.Lenong, L. & Bouvier, M. (2004). Structures ofHLA-A*1101 complexed with immunodominantnonamer and decamer HIV-1 peptides clearly revealthe presence of a middle, secondary anchor. Journalof Immunology, 172: 6175-6184.Lenong, L., Wang, S. & Bouvier, M. (2004, in press).Structural impact of natural polymorphism in theHLA-A3 superfamily: implications for antigenselection and presentation by HLA-A3-likemolecules. Journal of Immunology.Wang, S., Tan, Y., Stafford, W., Mabuchi, E. &Bouvier, M. Individual domains of calreticulin:identification of the calcium, zinc, and ATP bindingsites. Manuscript in preparation.DIANE J. BURGESSBurgess, D.J., Duffy, E., Etzler, F. & Hickey, A.J.(2004, in press). Particle Size Analysis: AAPSWorkshop Report. The AAPS Journal.Patil, S.D. & Burgess, D.J. (2004, in press). DNAbasedTherapeutics and their delivery systems: Acomprehensive review. The AAPS Journal.Burgess, D.J., Crommelin, D.J.A., Hussain, A.S. &Chen, M.L. (2004). Assuring quality andperformance of sustained and controlled releaseparenterals. European Journal of PharmaceuticalSciences, 21, (5) 679-690.ANDREA K. HUBBARDThibodeau, M., Giardina, C. & Hubbard, A.K.(2003). Silica Induced Caspase Activation In MouseAlveolar Macrophages Is Dependent UponMitochondrial Integrity And Aspartic Proteolysis.Toxicological Sciences, 76, 91-101.Fubini, B. & Hubbard, A.K. (2003). Role of ReactiveOxygen and Nitrogen Species (ROS/XRNS) in LungInjury and Diseases. Free Radical Biology Medicine,34, 1507-16.Symanowicz, P.T., Olsen, J.E., Thrall, R.S., Cloutier,M.M. & Hubbard, A.K. (2003). Immediate sensorynerve-mediated respiratory responses to irritants inhealthy and allergic airway-diseased mice. Journal ofApplied Physiology, 94, (4) 1563-71DEVENDRA S. KALONIASharma, V.K. & Kalonia, D. S. (2004). Effect ofVacuum Drying on Protein-Mannitol Interactions:The Physical State of Mannitol and ProteinStructure in Dried State. AAPS PharmSciTech, 5(1)Article 10FacuBurgess, D.J., Crommelin, D.J.A, Hussain, A.S. &Chen, M.L. (2004). Assuring quality andperformance of sustained and controlled releaseparenterals: EUFEPS Workshop Report. The AAPSJournal, 6, (1)11.Patil, S.D. & Burgess, D.J. (Commissioned 2003).DNA-based Bio-pharmaceuticals: Therapeutics forthe 21st Century. AAPS News Magazine.Jiao, J. & Burgess, D.J. (2003). Ostwald ripening ofwater-in-hydrocarbon emulsions. Journal of ColloidInterface Science, 264(2), 506-516.GERALD GIANUTSOSChicoine, L.M., Suppiramaniam, V., Vaithianathan, T.,Gianutsos, G. & Bahr, B.A. (2004). Sulfate- and sizedependentpolysaccharide modulation of AMPAreceptor properties. Journal of NeuroscienceResearch, 75, 408-416.DAVID F. GRANTEnayetallah, A. D., French, R. A., Thibodeau, M. S.& Grant, D. F. (2004). Distribution of solubleepoxide hydrolase and CYP2C8, 2C9 AND 2J2 innormal human tissues. Journal of Histochemistryand Cytochemistry, 52, 447-454.Nowak, G., Grant, D. F. & Moran, J. H. (2004).Linoleic acid epoxide, cis-12,13-epoxy-9-octadecenoicacid, promotes the maintenance of mitochondrialfunction and active Na + transport in renal cellsfollowing hypoxia. Toxicology Letters, 147, 161-175.Przybyla-Zawislak, B. D., Johana Vázquez-Matías, J.,Mohrenweiser, H. W., Maxwell, J., Hammock, B. D.,York, J. L., Zeldin, D. C. & Grant, D. F. (2003).Polymorphisms in human soluble epoxide hydrolase.Molecular Pharmacology, 64, 482-490.Sharma, V.K. & Kalonia, D.S. (2004). PolyethyleneGlycol-Induced Precipitation of Interferon Alpha-2aFollowed ByVacuum Drying: Development of aNovel Process for Obtaining a Dry, Stable Powder.AAPS Journal, 6(1), Article 4.Sharma, V.K. & Kalonia, D.S. (2003). Temperatureand pH Induced Multiple Partially Unfolded Statesof Recombinant Human Interferon alpha-2a,Possible Implications in Protein Stability.Pharmaceutical Research, 1721-1729, 20(11).Srivastava, P.K., Sharma, V., Kalonia, D. & Grant, D.Polymorphisms in Human Soluble EpoxideHydrolase: Effects on Enzyme Activity, EnzymeStability and Quaternary Structure. Accepted forpublication in the Archives of Biochemistry andBiophysics.ALEXANDROS MAKRIYANNISGuo, J., Pavlopoulos, S., Tian, X., Lu, D., Nikas, S.,Nikas, S., Yang, D. & Makriyannis, A. (2003).Conformational study of lipophilic ligands inphospholipid model membrane systems by solutionNMR. Journal of Medicinal Chemistry, 46, 4838-4846.Ibrahim, M. M., Deng, H., Zvonok, A., Cockayne,D., Kwan, J., Mata, H.P., Vanderah, T., Lai, J.,Porreca, F., Makriyannis, A. & Malan, T.P. (2003).Activation of CB 2cannabinoid receptors by AM1241inhibits experimental neuropathic pain: Paininhibition by receptors not present in CNS.Proceedings of the National Academy of Science,100, (18) 10529-33.Jarbe, T., Lamb, R., Liu, Q. & Makriyannis, A.(2003). (R)-Methanandamide and D 9 -tetrahydrocannabinol-induced operant ratedecreases in rats are not readily antagonized by SR-141716A. European Journal of Pharmacology, 466,121-127.

s - Faculty Publications for Academic Year 2003 - 2004Focus on FacultyKoufaki, M., Calogeropoulou, T., Rekka, E.,Chryselis, M., Papazafiri, P., Gaitanaki, C. &Makriyannis, A. (2003). Bifunctional Agents forReperfusion Arrhythmias: Novel Hybrid Vitamin E/Class I Anti-arrhythmics. Bio-organics & MedicinalChemistry, 11, 5209-5219.Makriyannis, A. & Goutopoulos, A. (2003).Cannabinergics: Old and New TherapeuticPossibilities. Drug Discovery Strategies and Methods,1, 89-128.McLaughlin, P.J., Winston, K., Swezey, L., Wisniecki,A., Aberman, J., Tardif, D.J, Betz, A.J., Ishiwari, K.,Makriyannis, A. & Salamone, J.D. (2003). Thecannabinoid CB1 antagonists SR141716A and AM251suppress food intake and food-reinforced behaviorin a variety of tasks in rats. BehaviouralPharmacology, 14, (8) 583-588.Papahatjis, D., Nikas, S., Kourouli, T., Chari, R., Xu,W., Pertwee, R.G. & Makriyannis, A. (2003).Pharmacophoric Requirements for the CannabinoidSide Chain: Probing the Cannabinoid Receptorsubsite at C1¢. Journal of Medicinal Chemistry, 46(15), 3221-9.Hohmann, A.G., Farthing, J.N., Zvonok, A.M. &Makriyannis, A. (2004). Selective Activation ofCannabinoid CB 2Receptors Suppresses HyperalgesiaEvoked by Intradermal Capsaicin. Journal ofPharmacology and Experimental Therapy, 308, 446-453.Czoty, P.W., Makriyannis, A. & Bergman, J. (2004,in press). Methamphetamine Discrimination and invivo Microdialysis in Squirrel Monkeys.Psychopharmacology.Guo, J., Pavlopoulos, S., Tian, X., Lu, D., Yang, D. &Makriyannis, A. (2004, in press). Conformationalstudy of lipophilic ligands in phospholipid modelmembrane systems by solution NMR. Journal ofMedicinal Chemistry.Luk, T., Jin, W., Zvonok, A., Lu, D., Lai, X., Chavkin,C., Makriyannis, A., & Mackie, K. (2004, in press).Identification of a potent and highly efficacious, yetslowly desensitizing CB1 cannabinoid receptoragonists. British Journal of Pharmacology.Nackley, A.G., Zvonok, A.M, Makriyannis, A. &Hohmann, A.G. (2004, in press). A PeripheralCannabinoid CB 2/sub Mechanism Modulates C-Fiber Evoked Responses and Windup of Spinal WideDynamic Range Neurons in a Rat Model ofInflammation. Journal of Neurophysiology.Jarbe, T. U. C., Harris, M.Y., Li, C., Liu, Q.,Makriyannis, A. (2004). Discriminative StimulusEffects of SR-141716, A Cannabinoid CB1 ReceptorAntagonist. Manuscript accepted toPsychopharmacology.Nikas, S. P., Grzybovska, J., Papahatjis, D.P.,Charalambous, A., Banijamali, A.R., Chari, R., Fan,P., Kourouli, T., Lin, S., Nitowski, A.J., Marciniak,G., Guo, Y., Li, X., Wang, C.J. & Makriyannis, A.(2004). The Role of Halogen Substitution inClassical Cannabinoids: A CB1 PharmacophoreModel. Manuscript accepted to the AAPS Journal.Choi, G., Guo, J. & Makriyanis, A. (2004). TheConformation of Helix 8 of the CB1 CannabinoidReceptor Using NMR and Circular Dichroism.Manuscript submitted to Biochimica et BiophysicaActa.ltyGifford, A.N., Deng, H., Makriyannis, A., Akinfeyele,T., Bruneus, M., DiMaio, A.A., Volkow, N.D. &Gatley, S.J. (2004). In vivo binding of the potentaminoalkylindole CB1 cannabinoid receptor agonist,AM2233. Manuscript submitted to the Journal ofPharmacology and Experimental Therapeutics.Guo, J., Pavlopoulos, S., Tian, X., Lu, D. &Makriyannis, A. (2004). Conformational studies ofhydrophobic small molecules in an anisotropicmembrane system using high resolution NMR.Manuscript submitted to Biochimica et BiophysicaActa.Xie, X-Q., Chen, J-Z., & Makriyannis, A. (2004).Structural Analyses of the C-TerminalJuxtamembrane Domains of G-Protein CoupledCannabinoid CB 1CB 2Receptors: A Comparative NMRStudy. Submitted to the Biophysical Journal.Zhang, W., Lin, S., Erickson, J., Makriyannis, A. &Redda, K.K. (2003). Synthesis of BiphenilicCannabinoid Analogs and Structure ActivityRelationship Studies. Submitted to the Jouenal ofMedicinal Chemistry.JOSE E. MANAUTOUChen, C., Hennig, G.E., & Manautou, J.E. (2003).Hepatobiliary excretion of acetaminophen and itsconjugated metabolites in transport deficient (TR - )hyperbilirubinemic rats. Drug Metabolism andDisposition, 31, 798-804.Shankar, K., Vaidya, V.S., Apte, U.M., Manautou,J.E., Ronis, M.J., Bucci, T.J., & Mehendale, H.M.(2003). Type 1 diabetic mice are protected fromacetaminophen hepatotoxicity. Toxicological Sciences,73, 220-34.Manautou, J.E. (2003). CAR inhibitors: new line oftreatment for APAP poisoning? Journal ofHepatology, 39, 297-299.JOHN B. MORRISMorris, J.B., Symanowicz, P.T., Olsen, J.E., Thrall, R.S.,Cloutier, M.M. & Hubbard, A.K. (2003).Immediate sensory-nerve mediated respiratoryresponses to irritants in healthy and allergic airwaydiseased mice. Journal of Applied Physiology, 94,1563-1571.Symanowicz, P.T., Gianutsos, G. & Morris, J.B.(2004). Lack of role for the vanilloid receptor inresponse to several inspired irritant air pollutants inthe C57Bl/6J mouse. Neuroscience Letters, 362,150-153.MICHAEL J. PIKALPikal, M. J., Chang, L. & Tang, X. (2004).Evaluiationof glassy-state dynamics from the width of the glasstransition: results from theoretical simulation ofdifferential scanning calorimetry and comparisonswith experiment. Journal of Pharmaceutical Sciences,93 (4) 981-994.Lu, X. & Pikal, M. J. (2004). Freeze-Drying ofMannitol-Trehalose-Sodium Chloride formulations:The Impact of Annealing on Dry Layer Resistanceto Mass Transfer and Cake Structure.Pharmaceutical Development & Technology, 9 (1),85-95.Tang, X., & Pikal, M. J. (2004). Design of Freeze-Drying Processes for Pharmaceuticals: PracticalAdvice. Pharmaceutical Research, 21(2), 191-200.SPIRO PAVLOPOULOSGuo, J., Pavlopoulos, S., Tian, X., Nikas, S.P, Lu, D.,Yang, D.P., Makriyannis, A. (2003). ConformationalStudy of Lipophilic Ligands in Phospholipid ModelMembrane Systems by Solution NMR. Journal ofMedicinal Chemistry, 46 (23) 4838-4846.21Jeffrey R. AeschlimannAssistant ProfessorDuring the past year, researchin the laboratory of JeffreyAeschlimann, Pharm.D., hasfocused on the relationshipbetween antimicrobialresistance and antimicrobialpharmacodynamics againstPseudomonas aeruginosa, acommon cause of bacterialinfections in critically illhospitalized patients.Completed projects havedocumented significantdifferences in the activity ofantipseudomonal antimicrobialsbased on whether the P.aeruginosa produces multidrugefflux pump proteins at low orhigh levels. Using a novel invitro infection model system, itwas determined that theoverproduction of these effluxAntimicrobial Resistance Researchpump systems results insignificant differences in overallantipseudomonal activity ofcombination therapies versusthis pathogen.Continuing research seeks todefine the impact of multidrugefflux pump-based resistanceon the clinical outcomes ofpatients with P. aeruginosainfections and ultimately isfocused on determining theoptimal way to treat patientswith these life-threateninginfections.

Faculty PublicationsDepartment of Pharmacy Practice - Faculty Publications for Academic Year 2003 - 2004JEFFERY AESCHLIMANNRybak, M.J. & Aeschlimann, J.R. (2004). LaboratoryTests to Direct Antimicrobial Chemotherapy.Pharmacotherapy: A Pathophysiologic Approach (6 thedition).Rybak, M.J. & Aeschlimann, J.R. (2004).Streptogramins. Antimicrobial Chemotherapy.White, R.L., Bonapace, C.R, Friedrich, L.V., Rybak,M.J., Cappelletty, D.M., Mercier, R.C., Houlihan, H.H,Aeschlimann, J.R. & Bosso, J.A. (2003). Assessmentof Differences in Antimicrobial Effect Determinedwith Two In Vitro Pharmacodynamic Models: Impactof Surface Area to Volume Ratio. Pharmacotherapy,23(5):603-608.MARLA CAMPBELLCampbell, M.J. Collaborative Drug TherapyManagement. (2004, in press). Pharmacy Law.Hammond, R.W., Schwartz, A.H., Campbell, M.J., et al.(2003). ACCP Position Statement: Collaborative DrugTherapy Management by Pharmacists.Pharmacotherapy, 23: 1210-1225.Carabino, J.M. & Campbell, M.J. (2003). Cost IssuesWhen Prescribing Chronic Pain Medications forCancer Patient with No Prescription Coverage.Caring Connections – Hospice of Bristol HospitalPatient and Family Newsletter, Volume 2, Issue 1.Lee, J., Neafsey, P., Campbell, M. & Facchinetti, N.(2003). Self-Efficacy and Knowledge of ConnecticutPharmacists Concerning Nutritional Supplementation.Connecticut Pharmacist, 62 (4): 8-15DENNIS CHAPRONChapron, D.J. Pharmacotherapy of Thyroid Diseasesin the Elderly. Geriatric Review Module sponsored bythe American Society of Consultant Pharmacists.Schneiderman, H., Chapron, D.J. & McMahon, E.(2004). Minocycline-Induced Skin Pigmentation.Consultant, 44:817-826.CRAIG COLEMANColeman, C.I., Hebert, J.H. & Reddy, P. (2003). Theeffect of Panax ginseng on quality of life. Journal ofClinical Pharmaceutical Therapy, 28:5-15.Coleman C.I., Musial, B.L. & Ross, J. (2003). Focus onenfuvirtide: The first fusion inhibitor for thetreatment of HIV-1 infection. Formulary, 38:202-220.Perkerson, K.A., White, C.M. & Coleman, C.I. (2003).Aldosterone receptor antagonists in heart failure.Connecticut Medicine, 67:397-401.Coleman, C.I., Reddy, P., Quercia, R.A., et al. (2003).A cost-benefit analysis of an inpatient, pharmacymanagedmedication assistance program for indigentpatients. American Journal of Health-SystemPharmacy, 60:378-82.Coleman, C.I., Carabino, J.M., Vergara, C.M., et al.(2003). Focus on vardenafil: An oral selectivephosphodiesterase inhibitor for the treatment oferectile dysfunction. Formulary, 38:131-48.Coleman, C.I., Reddy, P., Laster-Bradley, N.M., et al.(2003). Prescriber and Pharmacist Responses toIntervention Letters for Connecticut MedicaidBeneficiaries with Asthma. American Journal of Health-System Pharmacists, 60:1142-4.Coleman, C.I., Reddy, P., Laster-Bradley, N.M., et al.(2003). Effect of Practitioner Education on Adheranceto Asthma Treatment Guidelines. Annals ofPharmacotherapy, 37:956-61.Perkerson, K.A., Quercia, R.A., Goldman, M., Goddu,G. & Coleman, C.I. (2004). MultidisciplinaryApproach to Improving Adverse Drug ReactionReporting. Connecticut Medicine, 68:275-78.McBride, B.F., Karapanos, A.K., Krudysz, A., Kluger, J.,Coleman, C.I., et al. (2004). The Electrocardiographicand Hemodynamic Effects of Metabolife 356 inHealthy Volunteers. Journal of the American MedicalAssociation, 291:216-21.FacultyKalus, J.S.,White, C.M., Caron, M.F., Coleman, C.I., etal. (2004). Clinical Indicators of Postoperative AtrialFibrillation Risk in Cardiothoracic Surgery PatientsTreated with Prophylactic Amiodarone. Annals ofThoracic Surgery, 77:1288-92Coleman, C.I., Kalus, J., Caron, M.F., et al. (2004).Model of effect of magnesium prohylaxis onfrequency of Torsade de Pointes in ibutilide-treatedpatients. American Journal of Health-SystemsPharmacists, 61:685-88.Coleman, C.I., Perkerson, K.A. & Lewis, A. (2004).Alendronate-Induced Auditory Hallucinations andVisual Disturbances. Pharmacotherapy, 24(6).Ellis, J.M., Ross, J.W. & Coleman, C.I. (2004).Fosamprenavir: A novel protease inhibitor andprodrug of amprenavir. Formulary, 39:151-60.Musial, B.L., Chojenicki, J.K. & Coleman, C.I. (2004).Atazanavir: A new protease inhibitor to treat HIV-1infection. American Journal of Health-SystemPharmacy, 61(12).NEIL FACCHINETTIShah, S.A., Parisi, J.P., Facchinetti, N.J., & James, J.A.(2004). The impact of brief counseling intervention bypharmacists on readiness to quit smoking in acommunity pharmacy. New England Journal ofPharmacy, 31-34.Lee, J., Neafsey, P., Campbell, M., & Facchinetti, N.(2003) Self-Efficacy and Knowledge of ConnecticutPharmacists Concerning Nutritional Supplementation.Connecticut Pharmacist, 62 (4): 8-15.SEAN JEFFERYChamberlin, K.W., Pham, T. & Jeffery, S.M. (2004).Pain Management. Geriatric Pharmacy Review, 12.08;6.Jeffery, S.M. Spinal Cord Syndromes andNeuropathies. (2004). Geriatric Pharmacy Review,12.04.Chamberlin, K.W. & Jeffery, S.M. (2003). SleepDisorders in the Elderly. Geriatric Pharmacy Review,16.03.JENNIFER JAMESShah, S.A., Parisi, J.P., Facchinetti, N.J., & James, J.A.(2004). The Impact of Brief Pharmacist Counselingon Patient Readiness to Quit Smoking in aCommunity Setting. New England Journal ofPharmacy, 1 (1): 31-34.James, J.A. (2003). Patient Drug Facts: For PatientsWho Want to Know More. American Journal ofPharmaceutical Education, 67 (2), 24LISA LARIVELarive, L.L., Rhoney, D.H., Parker, D. & Carhuapoma,J.R. (2003). Initial Experience Using Hypertonic Salinefor Cerebral Edema. Journal of NeurosurgicalAnesthesiology, 15(4):375, A51.Rhoney, D.H., DiDonato, M. & Larive, L.L. (2003).National Survey of High-dose Steroid PrescribingPractices Following Spinal Cord Injury. Critical CareMedicine, 31(12 Suppl):A88 (320).Larive, L.L., & Rhoney, D.H. (2003). PrescribingPatterns for Antihypertensive Agents in IntracerebralHemorrhage. Critical Care Medicine, 31(12Suppl):A138(495).FEI WANGWang, F., Vergara, C.M., Carabino, J.M., Desilets, A.& Vasquez, R. (2004, in press). Continuation ofThiazolidinedione Therapy in Patients Without LeftVentricular Dysfunction Who Develop FluidRetention and Symptoms of Congestive HeartFailure. American Journal of Health-System Pharmacy.Vergara, C., Martin, A.M. & Wang, F. (2004)Horowitz, S. Awareness about Factors That Affectthe Management of Hypertension in Puerto RicanPatients. Connecticut Medicine, 68(5): 269-276.Wang, F. & Ross, J. (2003). Atazanavir: A NovelAzapeptide Inhibitor of HIV-1 Protease. Formulary,38:677-696.Wang, F., Carabino, J.M. & Vergara, C.M. (2003).Insulin Glargine: A Systematic Review of a LongActing Insulin Analog. Clinical Therapeutics, 25(6):1539-1577.Vergara, C.M., Wang, F. & Banfi, V. (submitted2003). Hypertension in Puerto Ricans in the UnitedStates: A Narrative Review. Journal of Health Carefor the Poor and Underserved.C. MICHAEL WHITEWhite, C.M., McBride, B., Kalus, J. (2004). Chapter2: Dyslipidemias. Pharmacotherapy Self AssessmentProgram, Fifth Ed., Book 1: Cardiology, 165-190.Coleman, C., Reddy, P., Laster-Bradley, N.M., Dorval,S., Munagala, B. & White, C.M. Prescriber andPharmacist Responses to Intervention: Letters forConnecticut Medicaid Beneficiaries with Asthma.Coleman, C., Reddy, P., Laster-Bradley, N.M., Dorval,S., Munagala, B., & White, C.M. (2003). Effect ofPractitioner Education on Adherence to AsthmaTreatment Guidelines. Annals of Pharmacotherapy,37:956-61.White, C.M., Caron, M.F., Kalus, J.S., Rose, H., Song,J., Reddy, P., Gallagher, R., Kluger, J. (2003).Intravenous and Oral Amiodarone, Atrial SeptalPacing, or Both Strategies to Prevent Post-Cardiothoracic Surgery Atrial Fibrillation: the AtrialFibrillation Suppression Trial II (AFIST II). 108[SupplII]: 200-6.Wu, A.H.B, Smith, A., Mather, J.F., Duncan, B.,White, C.M. & Heller, G.V. (2003). BiologicalVariation for NT-Pro- and B-Type NatriureticPeptides and Implications for TherapeuticMonitoring of Patients with Congestive HeartFailure. American Journal of Cardiology, 92:628-31.Taillefer, R., Ahlberg, A.W., Masood, Y., White,C.M., Lamargese, I., Mather, J.F., McGill, C.C. &Heller, G.V. (2003). Acute Beta-Blockade ReducesDipyridamole-Induced Myocardial Ischemia UsingTc-99m Sestamibi SPECT Imaging. Journal of theAmerican College of Cardiology, 42:1475-83.Kalus, J.S., Spencer, A.P., Tsikouris, J.P., Chung, J.,Kenyon, K.W., Ziska, M., Kluger, J. & White, C.M.(2003). The Impact of Prophylactic IntravenousMagnesium on the Efficacy of Ibutilide forConversion of Atrial Fibrillation or Flutter: TheTreatment with Ibutilide and Magnesium Evaluation(TIME). American Journal of Health-SystemsPharmacists, 60:2308-12.McBride, B.F., Karapanos, A.K., Krudysz, A., Kluger,J., Coleman, C.I., & White, C.M. (2004). TheElectrocardiographic and Hemodynamic Effects of aMulticomponent Dietary Supplement ContainingEphedra and Caffeine: a Randomized Trial. Journal ofthe American Medical Association, 291:216-21.Coleman, C.I., Kalus, J., Caron, M.F., Kluger, J.,White, C.M. (2004). Modeling the Impact ofProphylactic Magnesium on the Incidence ofTorsade de Pointes Among Patients ReceivingIbutilide. American Journal of Health-SystemsPharmacists, 51:685-8.Kalus, J.S., White, C.M., Caron, M.F., Coleman, C.I.,Takada, H. & Kluger, J. (2004). Indicators of AtrialFibrillation Risk in Cardiac Surgery Patients onProphylactic Amiodarone. Annals of ThoracicSurgery, 77:1288-92.McBride, B., White, C.M., Campbell, M. & Frey, B.(2003). Nicardipine to Control NeonatalHypertension During Extracorporeal MembranousOxygen (ECMO) Support. Annals ofPharmacotherapy, 37:667-70.White, C.M. (2003). Venlafaxine in EP Procedure: AClinical Case Review. Drug Topics, 147:HSE11.McBride, B. & White, C.M. (2003). AcuteDecompensated Heart Failure: A ContemporaryApproach to Pharmacotherapeutic Management.Pharmacotherapy, 997-1020.McBride, B.F. & White, C.M. (2003). Ranolazine: ANovel Metabolic Modulator for the Treatment ofChronic Stable Angina. Formulary, 38:461-6.McBride, B. & White, C.M. (2003). Levosimendan:Implications for Clinicians. Journal of ClinicalPharmacology, 43:1071-81.McBride, B. & White, C.M. (2004, in press). AreThere Ethnic Differences in Heart FailureMedication Response? Connecticut Medicine.Cheng, J.W., Frank, L., Garrett, S.D., Lu, Y., Sanoski,C.A. & White, C.M. (2004). Key Articles andGuidelines in Pharmaceutical Management ofArrhythmia. Pharmacotherapy, 24:248-279.Min, B. & White, C.M. (2004). Hawthorn.Connecticut Medicine, 68:161-4.

Department of Pharmacy Practice Residents and FellowsAcademic Year 2003 - 2004Focus on FacultyLeena BardwajPsychiatric Pharmacy FellowInstitute of LivingPreceptor - C. CaleyPatient Counseling LabKevin ChamberlinGeriatric Pharmacy ResidentVA Connecticut HealthCarePreceptor - S. JefferyMichael GurenPrimary Care ResidentHartford HospitalPreceptor - F. WangNeil J. FacchinettiAssociate ProfessorNeurotoxicology CenterBen A. BahrAssociate ProfessorBrian McBrideCardiovascular FellowHartford HospitalPreceptor - C.M. WhiteBokyung MinCardiovascular FellowHartford HospitalPreceptor - C.M. WhiteFletcher NehringPharmacy Practice ResidentSaint Francis HospitalPreceptor - M. SummaKristen PerkersonPharmacoeconomics FellowHartford HospitalPreceptor - C. ColemanNadine YangPharmacy Practice ResidentSaint Francis HospitalPreceptor - M. SummaThe development of excellentcommunications skills isessential to the profession ofpharmacy. The PatientCounseling Lab providesopportunities for activelearning by role-playing avariety of patient caresituations.In 2004, Pharmacy CounselingLab was converted to digitalvideo recording and viewingthrough a new streamingserver. The server stores morethan 500 video files from threenew camcorders and computersin recording stations andstreams them to three othernew computers in the labwhere students view them withtheir instructors.With this new equipment,worth more than $20,000,students and pharmacistinstructors are affordedenhanced opportunities toanalyze counseling sessionsboth on and off campus. Thenew computers, plus a newDVD player, permit thecreation and viewing ofinstructional DVDs that helpprepare students for theirrecording sessions.Dr. Ben Bahr, an associateprofessor of pharmacology andneurotoxicology in the Schoolof Pharmacy, is in the processof turning his researchlaboratory into aNeurotoxicology Center forthe University. He hassubmitted a request for patentprotection, that is currentlypending, on a revolutionarytreatment strategy forAlzheimer’s disease. Dr. Bahrhas also met with officials inthe UConn Research andDevelopment Corporation inorder to secure fundingthrough small businessinitiatives and the NationalInstitutes of Health. He haspresented his research at Pfizerin order to gain further localinterest.23

Boehringer Ingelheim Pledges $250,000 To UConn’s School of PharmacyBuilding UpdateThe faculty, staff and studentsof the School of Pharmacy areeagerly looking forward tobeing in our new building bythe beginning of the 2005-06academic year. The newPharmacy/Biology Building,which is centrally located in theresearch quadrangle acrossfrom the new ChemistryBuilding, has a distinctiveappearance due to its large sizeand unique constructionutilizing brick and pre-patinaedcopper. The interior walls areup and painting and installationof lab benches is wellunderway. Construction,which began in July 2003,should be completed by thesummer of 2005. It isanticipated that the School ofPharmacy will start moving intothe new building by June 2005and should be completelyrelocated by the beginning ofthe fall semester.Boehringer IngelheimPharmaceuticals, Inc. hascommitted $250,000 tosupport the School ofPharmacy and name the DosageForms Laboratory Suite in thenew Pharmacy/Biology Buildingwhich is currently underconstruction.The Boehringer IngelheimDosage Forms LaboratorySuite, a state-of-the-art facility,will be used for teaching andresearch in the areas of drugformulation, manufacturing,and quality assessment. Thedesign plans include a centrallaboratory, satellite unitoperations laboratory, satellitesterile compoundinglaboratory, and laboratorypreparation room.GrowingSave the DateFor the dedication of thePharmacy/Biology Buildingand the celebration of the80th Anniversary of theSchool of PharmacyOctober 21-22, 2005.Named Gift OpportunitiesOpportunities to name facilitiesand spaces in the newPharmacy/Biology Buildingabound. To date, more than$1,520,000 has been committedto name locations throughoutthe building. Contributionsdesignated to the School ofPharmacy Endowment for the21 st Century will position theSchool for further growth. Thisendowment will provide fundingfor student scholarships, faculty,and programmatic support. Ifyou would like to honor afamily member or be recognizedby naming a location in the newbuilding, please contact BrianLachapelle at (860) 486-6945 orblachapelle@foundation.uconn.edu.Library/Technology Center (1)$1,000,000Atrium (1)$250,000Dean’s Office Suite (1)$250,000Research Labs (39)$100,000 eachTerrace (1)$100,000Conference Rooms (2)$50,000 eachInterview Room (1)$50,000Faculty Offices (28)$25,000 eachFinance/Library Offices (2)$25,000 eachPeter Farina, Vice President forDevelopment at BoehringerIngelheim and a member of theSchool of Pharmacy’s AdvisoryBoard, said, “We are pleased tosupport UConn’s School ofPharmacy in promoting successin research.” Dean RobertMcCarthy said the closeprofessional relationship thathas developed betweenBoehringer Ingelheim scientistsand School of Pharmacy facultyover the years played animportant role in securing thepledge.“Dr. Farina has told me of thegreat respect that he and othersat the company have for ourfaculty as scientists andeducators,” he said. “In addition,several of our graduates havegone on to make importantcontributions at BoehringerIngelheim and their efforts havefurther enhanced our School’sreputation.”Within the Dosage FormsLaboratory Suite, the centrallaboratory will enable up to 30students at a time to learn howto prepare and assess a variety oftypes of nonsterile dosage forms.The satellite unit operationslaboratory will be dedicated tooperations that require isolation,such as tableting, granulating,coating, and preparation ofmicroemulsions. The satellitesterile compounding laboratorywill provide faculty with theopportunity to observe andteach proper sterilecompounding techniques. Thelaboratory preparation andstorage room will be used forthe preparation of stocksolutions for instructionalpurposes.“The Dosage FormsLaboratory Suite will facilitateteaching pharmacy studentshow to formulate and evaluatedrug products,” said McCarthy.“It will significantly enhance theSchool’s teaching and researchprograms.”Boehringer Ingelheim hasfunded other importantinitiatives at the School,including pre-doctoral andpost-doctoral fellowships.Pictured Below from Left to Right: Caswall Price, Dr. Peter Farina, Dr.Robin H. Bogner, UConn President Philip Austin, and Dean RobertMcCarthy

263700University of ConnecticutSchool of Pharmacy372 Fairfield Road, Unit 2092Storrs, Connecticut 06269-2092NON-PROFITORGANIZATIONU.S. POSTAGEPAIDSTORRS, CTPERMIT NO. 3